Back to Search
Start Over
Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
- Source :
- Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
- Publication Year :
- 2024
- Publisher :
- Nature Publishing Group, 2024.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20445385
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Blood Cancer Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.6e970035029749a08d3baafb531187a5
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41408-024-01155-y